The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ...

Area of Science:

• Pediatric Transplantation
• Immunology
• Oncology

Background:

• Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after pediatric solid organ transplantation.
• Epstein-Barr virus (EBV) is a key factor in the development of PTLD.
• Current prophylactic strategies for PTLD lack robust evidence.

Purpose of the Study:

• To review evidence on immunoprophylaxis, chemoprophylaxis, and pre-emptive strategies for PTLD in pediatric transplant recipients.
• To develop evidence-based recommendations for PTLD prevention.
• To identify gaps in current knowledge and future research priorities.

Main Methods:

• Systematic literature review of existing evidence.
• Expert consensus conference convened by the International Pediatric Transplant Association (IPTA).
• Focus on the Prevention Working Group's assessment of prophylactic and pre-emptive PTLD strategies.

Main Results:

• A strong recommendation was made for pre-emptive reduction of immunosuppression upon detection of EBV DNAemia (low to moderate evidence).
• No recommendations could be made for immunoprophylaxis, chemoprophylaxis, or alternative pre-emptive strategies due to insufficient or conflicting evidence.
• Significant gaps in research were identified regarding PTLD prevention.

Conclusions:

• Pre-emptive immunosuppression reduction is recommended for EBV DNAemia in pediatric transplant patients.
• Further research is crucial to establish effective prophylactic and pre-emptive strategies for PTLD.
• Addressing PTLD prevention remains a critical area in pediatric transplantation care.